Detailed price information for Tourmaline Bio Inc (TRML-Q) from The Globe and Mail including charting and trades.

SABCS ® "Spotlight” poster to be presented on Wednesday, December 11, 2024 7:00 AM - 8:30 AM CST highlights positive BriaCell survival and clinical benefit data across all metastatic breast cancer ...

On September 12 th, Bright Minds Biosciences announced the initiation of the BREAKTHROUGH Study, an open-label Phase 2 clinical trial evaluating the safety, tolerability, and efficacy of BMB-101 in ...

Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...

Have the traditions of science—rituals of poster presentations and tenure positions—evolved by chance? Would the origins of these practices pass the scientific test of repeatability? To echo Stephen ...

Tonix Pharmaceuticals (TNXP) presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, held November 14-19, 2024, in ...

Atea Pharmaceuticals (AVIR) announced it presented three poster presentations supporting the combination of bemnifosbuvir and ruzasvir as a potential treatment for hepatitis C virus, or HCV.

or download PDFs of abstracts for all annual meeting presentations. Read about the scientific imagery used at annual meetings, and in annual reports, and SfN merchandise, past and present.

results in breast cancer patients accepted for poster presentation on December 11, 2024 at the San Antonio Breast Cancer Symposium (SABCS) Jaguar initiated commercial launch in October 2024 for ...

"We are pleased to spotlight continued achievement across our pre-clinical pipeline as we develop a diverse portfolio of iNK, γδ iT, and αβ iT-cell programs spanning oncology and autoimmune diseases,” ...